Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/ENLIVEX-THERAPEUTICS-LTD-56422776/news/Enlivex-gibt-Topline-Ergebnisse-seiner-Phase-II-Studie-zur-Bewertung-von-Allocetra-bei-Patienten-mi-46415507/?utm_source=whatsapp&utm_medium=social&utm_campaign=share